← back to search

Cheng Tao

Fudan University · CN
🔎 Find collaborators in Biomedical Engineering · Rheumatology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Biomedical Engineering · Rheumatology
Research interest
Research interests include Cancer research, Apoptosis, Biology, Cell cycle, Cell cycle checkpoint, and Senescence.
h-index
citations
300
works
9
NIH funding
primary concept
email

Recent publications

Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma
Cancer Letters 2025cited by 7position: middledoi
Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3‐mediated N6‐methyladenosine modification of <i>ICAM2</i> mRNA in fibroblast‐like synoviocytes
Clinical and Translational Medicine 2022cited by 39position: middledoi
Demethyleneberberine induces cell cycle arrest and cellular senescence of NSCLC cells via c-Myc/HIF-1α pathway
Phytomedicine 2021cited by 49position: middledoi
N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes
Phytomedicine 2021cited by 40position: middledoi
CuS–NiS<sub>2</sub> nanomaterials for MRI guided phototherapy of gastric carcinoma <i>via</i> triggering mitochondria-mediated apoptosis and MLKL/CAPG-mediated necroptosis
Nanotoxicology 2020cited by 57position: middledoi
Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo
Cancer Chemotherapy and Pharmacology 2020cited by 40position: middledoi
CT1-3, a novel magnolol-sulforaphane hybrid suppresses tumorigenesis through inducing mitochondria-mediated apoptosis and inhibiting epithelial mesenchymal transition
European Journal of Medicinal Chemistry 2020cited by 24position: firstdoi
CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis
Bioorganic & Medicinal Chemistry 2020cited by 14position: middledoi
Artemether Attenuates the Progression of Non-small Cell Lung Cancer by Inducing Apoptosis, Cell Cycle Arrest and Promoting Cellular Senescence
Biological and Pharmaceutical Bulletin 2019cited by 30position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jian Chen · First Affiliated Hospital of Guangzhou Medical University8 papers (2019–2022)Zhengzhi Wu · Shenzhen Second People's Hospital5 papers (2019–2020)Xiaofei Huang · Guangzhou University of Chinese Medicine5 papers (2020–2021)Xinping Li · Handan College4 papers (2019–2020)Min Ma · Fudan University4 papers (2019–2020)Zide Chen · Jinan University4 papers (2020–2020)Qiang Zeng · Shanghai Jiao Tong University3 papers (2019–2020)Xian Lin · Third Affiliated Hospital of Sun Yat-sen University2 papers (2021–2022)Miaomiao Zhang · South China Agricultural University2 papers (2021–2022)Ren Zhang · Guangzhou University of Chinese Medicine2 papers (2020–2021)Qingwen Wang · Ningbo University2 papers (2021–2022)Miaomiao Yuan · Hunan University1 papers (2020–2020)Guangyao Shan · Fudan University1 papers (2025–2025)Rongjun Zhang · Fudan University1 papers (2020–2020)Di Ge · Nanjing University of Information Science and Technology1 papers (2025–2025)Youqin Xu · Southern Medical University1 papers (2020–2020) · 1 papers (2022–2022)Jianlong Zhou · University of Technology Sydney1 papers (2020–2020)Guoshu Bi · Sun Yat-sen University1 papers (2025–2025)Yinghong Li · Xi'an Jiaotong University1 papers (2020–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Biomedical Engineering · Rheumatology →